Biblio

Export 1181 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is D  [Clear All Filters]
2023
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., “Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
V. E Daniel, Kleiman, M. J., and Galvin, J. E., “Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.”, J Alzheimers Dis, vol. 91, no. 1, pp. 495-506, 2023.
T. Daly, Henry, V., and Bourdenx, M., “From Association to Intervention: The Alzheimer's Disease-Associated Processes and Targets (ADAPT) Ontology.”, J Alzheimers Dis, vol. 94, no. s1, pp. S87-S96, 2023.
A. Abraham Daniel, Silzer, T., Sun, J., Zhou, Z., Hall, C., Phillips, N., and Barber, R., “Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1229-1239, 2023.
J. R. Petrella, Michael, A. M., Qian, M., Nwosu, A., Sneed, J., Goldberg, T. E., Devanand, D. P., and P Doraiswamy, M., “Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 483-494, 2023.
J. R. Petrella, Michael, A. M., Qian, M., Nwosu, A., Sneed, J., Goldberg, T. E., Devanand, D. P., and P Doraiswamy, M., “Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 483-494, 2023.
T. Daly, “JAD: A Forum for Philosophy in Science.”, J Alzheimers Dis, vol. 95, no. 2, pp. 411-413, 2023.
S. M. de la Monte, “Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).”, J Alzheimers Dis, vol. 95, no. 4, pp. 1301-1337, 2023.
J. Alexander Jarholm, Bjørnerud, A., Dalaker, T. Olene, Akhavi, M. Sadat, Kirsebom, B. Eivind, Pålhaugen, L., Nordengen, K., Grøntvedt, G. Rolfseng, Nakling, A., Kalheim, L. F., Almdahl, I. S., Tecelao, S., Fladby, T., and Selnes, P., “Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.”, J Alzheimers Dis, vol. 94, no. 1, pp. 259-279, 2023.
N. Nagaraja, Wang, W. - E., Duara, R., DeKosky, S. T., and Vaillancourt, D., “Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 2, pp. 495-507, 2023.
N. Nagaraja, Wang, W. - E., Duara, R., DeKosky, S. T., and Vaillancourt, D., “Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 2, pp. 495-507, 2023.
I. De Anda-Duran, Kolachalama, V. B., Carmichael, O. T., Hwang, P. H., Fernandez, C., Au, R., Bazzano, L. A., and Libon, D. J., “Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.”, J Alzheimers Dis, vol. 94, no. 1, pp. 101-113, 2023.
L. Fenton, S Han, D., DiGuiseppi, C. G., Fowler, N. R., Hill, L., Johnson, R. L., Peterson, R. A., Knoepke, C. E., Matlock, D. D., Moran, R., Karlawish, J., and Betz, M. E., “Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1607-1615, 2023.
D. J. Quintana-Hernández, Rojas-Hernández, J., Del Pino, A. Santana-, Suárez, C. Céspedes, Silva, M. Pellejero, Miró-Barrachina, M. Teresa, Fernández, I. Ibáñez, López, J. Antonio Es, and Borkel, L. F., “Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 471-481, 2023.
C. Bernardes, Lima, M., Duro, D., Silva-Spínola, A., Durães, J., Tábuas-Pereira, M., Baldeiras, I., Freitas, S., and Santana, I., “Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1173-1182, 2023.
C. Bernardes, Lima, M., Duro, D., Silva-Spínola, A., Durães, J., Tábuas-Pereira, M., Baldeiras, I., Freitas, S., and Santana, I., “Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1173-1182, 2023.
S. Baez, Trujillo-Llano, C., de Souza, L. Cruz, Lillo, P., Forno, G., Santamaría-García, H., Okuma, C., Alegria, P., Huepe, D., Ibáñez, A., Decety, J., and Slachevsky, A., “Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 92, no. 1, pp. 153-169, 2023.
S. Baez, Trujillo-Llano, C., de Souza, L. Cruz, Lillo, P., Forno, G., Santamaría-García, H., Okuma, C., Alegria, P., Huepe, D., Ibáñez, A., Decety, J., and Slachevsky, A., “Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 92, no. 1, pp. 153-169, 2023.
M. P. Pase, Pinheiro, A., Rowsthorn, E., Demissie, S., Hurmez, S., Aparicio, H., Rodriguez-Lara, F., Gonzales, M. M., Beiser, A., DeCarli, C., Seshadri, S., and Romero, J. Rafael, “MRI Visible Perivascular Spaces and the Risk of Incident Mild Cognitive Impairment in a Community Sample.”, J Alzheimers Dis, vol. 96, no. 1, pp. 103-112, 2023.
M. P. Pase, Pinheiro, A., Rowsthorn, E., Demissie, S., Hurmez, S., Aparicio, H., Rodriguez-Lara, F., Gonzales, M. M., Beiser, A., DeCarli, C., Seshadri, S., and Romero, J. Rafael, “MRI Visible Perivascular Spaces and the Risk of Incident Mild Cognitive Impairment in a Community Sample.”, J Alzheimers Dis, vol. 96, no. 1, pp. 103-112, 2023.
A. A. Bahrani, Abner, E. L., DeCarli, C. S., Barber, J. M., Sutton, A. C., Maillard, P., Sandoval, F., Arfanakis, K., Yang, Y. - C., Evia, A. M., Schneider, J. A., Habes, M., Franklin, C. G., Seshadri, S., Satizabal, C. L., Caprihan, A., Thompson, J. F., Rosenberg, G. A., Wang, D. J. J., Jann, K. B., Zhao, C., Lu, H., Rosenberg, P. B., Albert, M. S., Ali, D. G., Singh, H., Schwab, K., Greenberg, S. M., Helmer, K. G., Powel, D. K., Gold, B. T., Goldstein, L. B., Wilcock, D. M., and Jicha, G. A., “Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.”, J Alzheimers Dis, vol. 96, no. 2, pp. 683-693, 2023.
X. Da, Hempel, E., Ou, Y., Rowe, O. Elizabeth, Malchano, Z., Hajós, M., Kern, R., Megerian, J. Thomas, and Cimenser, A., “Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 359-372, 2023.
Z. - Di Xia, Ma, R. - X., Wen, J. - F., Zhai, Y. - F., Wang, Y. - Q., Wang, F. - Y., Liu, D., Zhao, X. - L., Sun, B., Jia, P., and Zheng, X. - H., “Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1265-1301, 2023.
S. Ukraintseva, Duan, H., Holmes, R., Bagley, O., Wu, D., Yashkin, A., Kulminski, A., Akushevich, I., Whitson, H., Stallard, E., Yashin, A., and Arbeev, K., “Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 163-170, 2023.
E. S. Brook, D'Alonzo, Z. J., Lam, V., Chan, D., Dhaliwal, S. Singh, Watts, G. F., Mamo, J. C. L., and Takechi, R., “Plasma Amyloid-β Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.”, J Alzheimers Dis, vol. 93, no. 2, pp. 653-664, 2023.

Pages